These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21714932)

  • 41. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans.
    Kim HK; Lee JB; Kim SH; Jo MW; Kim EH; Hwang JY; Bae SJ; Jung CH; Lee WJ; Park JY; Park GM; Kim YH; Choe J
    J Diabetes; 2016 Sep; 8(5):657-66. PubMed ID: 26355268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study.
    van 't Riet E; Rijkelijkhuizen JM; Alssema M; Nijpels G; Stehouwer CD; Heine RJ; Dekker JM
    Eur J Prev Cardiol; 2012 Feb; 19(1):23-31. PubMed ID: 20517157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.
    Saito Y; Shirai K; Sasaki N; Shinomiya M; Yoshida S;
    J Atheroscler Thromb; 2002; 9(2):99-108. PubMed ID: 12236319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
    Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
    Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.
    Shimamoto K; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Itakura H;
    Hypertens Res; 2005 Nov; 28(11):879-87. PubMed ID: 16555576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE).
    Ouchi Y; Ohashi Y; Ito H; Saito Y; Ishikawa T; Akishita M; Shibata T; Nakamura H; Orimo H;
    Curr Ther Res Clin Exp; 2006 Jul; 67(4):241-56. PubMed ID: 24678100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
    Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N
    Ann Intern Med; 2004 Sep; 141(6):413-20. PubMed ID: 15381514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen/progesterone replacement versus pravastatin and their sequential association in hypercholesterolemic postmenopausal women.
    Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
    Maturitas; 2001 Dec; 40(3):247-57. PubMed ID: 11731186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
    J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between HbA
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Diabetes Metab; 2018 Nov; 44(5):415-423. PubMed ID: 29449147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
    Du T; Yuan G; Zhou X; Sun X
    Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between the effect of pravastatin and risk factors for coronary heart disease in Japanese patients with hypercholesterolemia.
    Ishikawa T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
    Circ J; 2008 Oct; 72(10):1576-82. PubMed ID: 18756039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
    Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    Margolis KL; Davis BR; Baimbridge C; Ciocon JO; Cuyjet AB; Dart RA; Einhorn PT; Ford CE; Gordon D; Hartney TJ; Julian Haywood L; Holtzman J; Mathis DE; Oparil S; Probstfield JL; Simpson LM; Stokes JD; Wiegmann TB; Williamson JD;
    J Clin Hypertens (Greenwich); 2013 Aug; 15(8):542-54. PubMed ID: 23889716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.
    Jarmul JA; Pignone M; Pletcher MJ
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):501-7. PubMed ID: 26349840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diet and pravastatin in moderate hypercholesterolaemia: a randomized trial in 215 middle-aged men free from cardiovascular disease.
    Bak AA; Huizer J; Leijten PA; Rila H; Grobbee DE
    J Intern Med; 1998 Nov; 244(5):371-8. PubMed ID: 9845852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.
    Orchard TJ; Stevens LK; Forrest KY; Fuller JH
    Int J Epidemiol; 1998 Dec; 27(6):976-83. PubMed ID: 10024191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
    Yamakawa T; Takano T; Utsunomiya H; Kadonosono K; Okamura A
    Endocr J; 2007 Feb; 54(1):53-8. PubMed ID: 17102570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.